Related Experiment Video
Updated: Jun 25, 2025
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.6K
Emerging Biohybrids of Aptamer-Based Nano-Biosensing Technologies for Effective Early Cancer Detection
Thimmaiah Bargavi Ram1, Saravanan Krishnan2, Jaison Jeevanandam3
1Department of Textile Engineering, Anna University, Chennai, Tamil Nadu, India.
Molecular Diagnosis & Therapy
|May 22, 2024
Summary
Aptamer-based nano-biosensors offer superior cancer detection. These advanced tools enhance early diagnosis and patient outcomes by improving specificity and sensitivity for cancer biomarkers.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Cancer remains a major global health challenge, necessitating improved early detection methods.
- Aptamers are highly effective biorecognition molecules for cancer cell identification, offering advantages over antibodies in specificity and stability.
- Nano-biosensing technologies integrating aptamers show promise for advanced diagnostics.
Purpose of the Study:
- To review diagnostic strategies utilizing aptamer-based biohybrid nano-biosensing technologies for cancer detection.
- To highlight the role of aptamers in identifying cancer biomarkers and abnormal cells.
- To explore recent advancements in nano-aptamer synthesis and their application in cancer diagnostics.
Main Methods:
- Review of literature on aptamer-based biohybrid nano-biosensing technologies.
- Synthesis and characterization of nano-aptamers using various nanomaterials (metallic nanoparticles, metal oxides, carbon-based substances, biohybrid nanostructures).
- Evaluation of aptamer-nanomaterial integration for enhanced sensitivity and specificity in cancer detection.
Main Results:
- Nano-aptamers synthesized with diverse nanomaterials demonstrate enhanced binding affinity and stability.
- Integration of aptamers with nanomaterials significantly improves sensitivity and specificity for cancer biomarker detection.
- Aptamer-based nano-biosensors provide innovative and efficient approaches for early cancer diagnosis.
Conclusions:
- Aptamer-based biohybrid nano-biosensing technologies represent a significant advancement in cancer diagnostics.
- The synergy between nanotechnology and aptamer research offers potential for rapid, accurate, and non-invasive cancer detection.
- These technologies hold promise for revolutionizing cancer treatment through improved diagnostic capabilities.
